Results 41 to 50 of about 45,912 (262)

Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.

open access: yes, 2007
Vietnam currently produces an orally administered, bivalent (O1 and O139) killed whole-cell vaccine and is the only country in the world with endemic cholera to use an oral cholera vaccine in public health practice.
Anh, Dang Duc   +13 more
core   +1 more source

Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea (Review) [PDF]

open access: yes, 2013
Background Infection with enterotoxigenic Escherichia coli (ETEC) bacteria is a common cause of diarrhoea in adults and children in developing countries and is a major cause of 'travellers' diarrhoea' in people visiting or returning from endemic regions.
Ahmed, Tanvir   +4 more
core   +3 more sources

Considerations for Oral Cholera Vaccine Use during Outbreak after Earthquake in Haiti, 2010−2011

open access: yesEmerging Infectious Diseases, 2011
Oral cholera vaccines (OCVs) have been recommended in cholera-endemic settings and preemptively during outbreaks and complex emergencies. However, experience and guidelines for reactive use after an outbreak has started are limited. In 2010, after over a
Kashmira A. Date   +12 more
doaj   +1 more source

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges. [PDF]

open access: yes, 2019
Introduction: Tuberculosis (TB) remains a major health threat and it is now clear that the current vaccine, BCG, is unable to arrest the global TB epidemic. A new vaccine is needed to either replace or boost BCG so that a better level of protection could
Barclay WR   +8 more
core   +1 more source

Knowledge of Cholera Among Syrians: A Cross-Sectional Study

open access: yesInternational Journal of Medical Students, 2022
Background: Cholera is a communicable acute bacterial infection caused by a gram-negative bacterium that is Vibrio Cholera. Worldwide, is estimated that an incidence of 1.3–4.0 millions of cholera infection, leading to 21,000–143,000 deaths annually ...
Mohammad Badr Almoshantaf   +6 more
doaj  

Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine.

open access: yesPLoS Neglected Tropical Diseases, 2021
Vibrio cholerae is a bacterial pathogen which causes the severe acute diarrheal disease cholera. Given that a symptomatic incident of cholera can lead to long term protection, a thorough understanding of the immune response to this pathogen is needed to ...
Oluwaseyi Adekunle   +5 more
doaj   +1 more source

Engineered Probiotics: The Next‐Generation Therapeutics to Combat Antibiotic‐Resistant Bacterial Infections

open access: yesFood Frontiers, EarlyView.
Engineered probiotics secretes fusion proteins which potentially neutralized the toxins secreted by other microbial communities. ABSTRACT On a global scale, the escalating burden of infectious diseases, predominantly attributed to bacterial pathogens, especially drug‐resistant strains, has progressed into a critical concern for clinical management and ...
Indu Singh   +11 more
wiley   +1 more source

A Mathematical Model on the Dynamics of In-Host Infection Cholera Disease with Vaccination

open access: yesDiscrete Dynamics in Nature and Society, 2023
In this paper, a within-host cholera mathematical model has been developed using a system of ordinary differential equations incorporating vaccine efficacy.
Owade Kennedy Jackob   +2 more
doaj   +1 more source

Mitigating Health Disparities Through Empathetic Policymaking During Times of Crisis

open access: yesPublic Administration and Development, EarlyView.
ABSTRACT The COVID‐19 pandemic greatly exacerbated the existing disparities and inequities in health and healthcare among historically marginalized populations. Today, these impacts still echo. These persistent structured inequities erode the public's trust in government, lead to failure in public policies, and result in worse health consequences ...
Yali Pang   +2 more
wiley   +1 more source

The role of vaccine coverage within social networks in cholera vaccine efficacy. [PDF]

open access: yesPLoS ONE, 2011
Traditional vaccine trial methods have an underlying assumption that the effect of a vaccine is the same throughout the trial area. There are, however, many spatial and behavioral factors that alter the rates of contact among infectious and susceptible ...
Elisabeth D Root   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy